Abstract
In recent years, prostate specific membrane antigen (PSMA) PET has attracted attention in the diagnosis of recurrence and metastasis of prostate cancer. PSMA is a membrane protein which shows increased expression in more than 90% of prostate cancer, and is known to exhibit high expression in many metastatic and recurrent lesions. In Osaka University Hospital, a clinical research using [18F]PSMA-1007 PET has been conducted since September 2019, and more than 150 scans has been performed so far in patients with prostate cancer with various stages.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have